Technical Analysis for RHHBY - Roche Hldg Ltd Spons

Grade Last Price % Change Price Change
grade A 34.02 0.80% 0.2700
RHHBY closed up 0.8 percent on Friday, February 15, 2019, on 44 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical RHHBY trend table...

Date Alert Name Type % Chg
Feb 15 New 52 Week Closing High Bullish 0.00%
Feb 15 New 52 Week High Strength 0.00%
Feb 15 Overbought Stochastic Strength 0.00%
Feb 14 Outside Day Range Expansion 0.80%
Feb 14 Overbought Stochastic Strength 0.80%
Feb 13 New Uptrend Bullish 1.28%
Feb 13 Narrow Range Bar Range Contraction 1.28%
Feb 13 Overbought Stochastic Strength 1.28%
Feb 12 New 52 Week Closing High Bullish 0.44%
Feb 12 New 52 Week High Strength 0.44%

Older signals for RHHBY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Companies Industries Life Sciences Pharmaceutical Industry In China Disease Infectious Diseases Pharmaceutical Products Neuroscience Diabetes Care Hoffmann La Roche Chugai Pharmaceutical Co. Gene Expression Genentech Roche
Is RHHBY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 34.02
52 Week Low 26.3
Average Volume 1,628,542
200-Day Moving Average 30.1222
50-Day Moving Average 32.0961
20-Day Moving Average 33.0273
10-Day Moving Average 33.6195
Average True Range 0.3953
ADX 27.44
+DI 35.1509
-DI 14.6114
Chandelier Exit (Long, 3 ATRs ) 32.8341
Chandelier Exit (Short, 3 ATRs ) 33.1359
Upper Bollinger Band 34.3779
Lower Bollinger Band 31.6767
Percent B (%b) 0.87
BandWidth 8.178689
MACD Line 0.5334
MACD Signal Line 0.4899
MACD Histogram 0.0435
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.4250
Resistance 3 (R3) 34.3800 34.2000 34.3575
Resistance 2 (R2) 34.2000 34.0969 34.2225 34.3350
Resistance 1 (R1) 34.1100 34.0331 34.1550 34.1550 34.3125
Pivot Point 33.9300 33.9300 33.9525 33.9525 33.9300
Support 1 (S1) 33.8400 33.8269 33.8850 33.8850 33.7275
Support 2 (S2) 33.6600 33.7631 33.6825 33.7050
Support 3 (S3) 33.5700 33.6600 33.6825
Support 4 (S4) 33.6150